{"id":4682,"date":"2024-03-18T15:30:27","date_gmt":"2024-03-18T15:30:27","guid":{"rendered":"https:\/\/www.peregrinevc.com\/?p=4682"},"modified":"2024-03-19T10:44:03","modified_gmt":"2024-03-19T10:44:03","slug":"nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding","status":"publish","type":"post","link":"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/","title":{"rendered":"Nectin Therapeutics has been honored with the esteemed European Innovation Council (EIC) Accelerator funding."},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"4682\" class=\"elementor elementor-4682\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-bd1fc17 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"bd1fc17\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-c31cedc\" data-id=\"c31cedc\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-013feeb elementor-widget elementor-widget-text-editor\" data-id=\"013feeb\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>Among 1083 proposals, Nectin emerged as one of the 42 recipients of EIC funding, highlighting the promise of its groundbreaking cancer immunotherapy pipeline.<\/p><p><span style=\"color: var( --e-global-color-text );\">Nectin has received an initial grant of \u20ac2.5M and stands to potentially secure up to \u20ac15M in equity, from the European Innovation Council and SMEs Executive Agency (EISMEA).<\/span><\/p>\n<p><\/p>\n<p>With this grant, Nectin will continue developing its innovative immunotherapy drug candidate, paving the way for significant advancements in cancer care and potentially offering new hope for patients.<\/p>\n<p><\/p>\n<p>This marks Peregrine&#8217;s second company to receive this accolade, a rare achievement both in Europe and, particularly, in Israel. Restore Medical was the initial recipient.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Among 1083 proposals, Nectin emerged as one of the 42 recipients of EIC funding, highlighting the promise of its groundbreaking cancer immunotherapy pipeline. Nectin has received an initial grant of \u20ac2.5M and stands to potentially secure up to \u20ac15M in equity, from the European Innovation Council and SMEs Executive Agency (EISMEA). With this grant, Nectin [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":4765,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[7],"tags":[],"class_list":["post-4682","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nectin Therapeutics has been honored with the esteemed European Innovation Council (EIC) Accelerator funding. - Peregrine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nectin Therapeutics has been honored with the esteemed European Innovation Council (EIC) Accelerator funding. - Peregrine\" \/>\n<meta property=\"og:description\" content=\"Among 1083 proposals, Nectin emerged as one of the 42 recipients of EIC funding, highlighting the promise of its groundbreaking cancer immunotherapy pipeline. Nectin has received an initial grant of \u20ac2.5M and stands to potentially secure up to \u20ac15M in equity, from the European Innovation Council and SMEs Executive Agency (EISMEA). With this grant, Nectin [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/\" \/>\n<meta property=\"og:site_name\" content=\"Peregrine\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-18T15:30:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-19T10:44:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2024\/03\/news-nectin.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Amit Alfasi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Amit Alfasi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/\"},\"author\":{\"name\":\"Amit Alfasi\",\"@id\":\"https:\/\/www.peregrinevc.com\/#\/schema\/person\/7cf18986a83be1600a6ceecb2f6ed521\"},\"headline\":\"Nectin Therapeutics has been honored with the esteemed European Innovation Council (EIC) Accelerator funding.\",\"datePublished\":\"2024-03-18T15:30:27+00:00\",\"dateModified\":\"2024-03-19T10:44:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/\"},\"wordCount\":117,\"publisher\":{\"@id\":\"https:\/\/www.peregrinevc.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2024\/03\/news-nectin.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/\",\"url\":\"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/\",\"name\":\"Nectin Therapeutics has been honored with the esteemed European Innovation Council (EIC) Accelerator funding. - Peregrine\",\"isPartOf\":{\"@id\":\"https:\/\/www.peregrinevc.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2024\/03\/news-nectin.jpg\",\"datePublished\":\"2024-03-18T15:30:27+00:00\",\"dateModified\":\"2024-03-19T10:44:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/#primaryimage\",\"url\":\"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2024\/03\/news-nectin.jpg\",\"contentUrl\":\"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2024\/03\/news-nectin.jpg\",\"width\":800,\"height\":400,\"caption\":\"Nectin Therapeutics has been honored with the esteemed European Innovation Council (EIC) Accelerator funding.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.peregrinevc.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nectin Therapeutics has been honored with the esteemed European Innovation Council (EIC) Accelerator funding.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.peregrinevc.com\/#website\",\"url\":\"https:\/\/www.peregrinevc.com\/\",\"name\":\"Peregrine\",\"description\":\"Venture Capital Fund\",\"publisher\":{\"@id\":\"https:\/\/www.peregrinevc.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.peregrinevc.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.peregrinevc.com\/#organization\",\"name\":\"PEREGRINE VENTURES\",\"url\":\"https:\/\/www.peregrinevc.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.peregrinevc.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/02\/logo.svg\",\"contentUrl\":\"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/02\/logo.svg\",\"width\":1,\"height\":1,\"caption\":\"PEREGRINE VENTURES\"},\"image\":{\"@id\":\"https:\/\/www.peregrinevc.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.peregrinevc.com\/#\/schema\/person\/7cf18986a83be1600a6ceecb2f6ed521\",\"name\":\"Amit Alfasi\",\"url\":\"https:\/\/www.peregrinevc.com\/author\/amit\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nectin Therapeutics has been honored with the esteemed European Innovation Council (EIC) Accelerator funding. - Peregrine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/","og_locale":"en_US","og_type":"article","og_title":"Nectin Therapeutics has been honored with the esteemed European Innovation Council (EIC) Accelerator funding. - Peregrine","og_description":"Among 1083 proposals, Nectin emerged as one of the 42 recipients of EIC funding, highlighting the promise of its groundbreaking cancer immunotherapy pipeline. Nectin has received an initial grant of \u20ac2.5M and stands to potentially secure up to \u20ac15M in equity, from the European Innovation Council and SMEs Executive Agency (EISMEA). With this grant, Nectin [&hellip;]","og_url":"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/","og_site_name":"Peregrine","article_published_time":"2024-03-18T15:30:27+00:00","article_modified_time":"2024-03-19T10:44:03+00:00","og_image":[{"width":800,"height":400,"url":"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2024\/03\/news-nectin.jpg","type":"image\/jpeg"}],"author":"Amit Alfasi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Amit Alfasi","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/#article","isPartOf":{"@id":"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/"},"author":{"name":"Amit Alfasi","@id":"https:\/\/www.peregrinevc.com\/#\/schema\/person\/7cf18986a83be1600a6ceecb2f6ed521"},"headline":"Nectin Therapeutics has been honored with the esteemed European Innovation Council (EIC) Accelerator funding.","datePublished":"2024-03-18T15:30:27+00:00","dateModified":"2024-03-19T10:44:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/"},"wordCount":117,"publisher":{"@id":"https:\/\/www.peregrinevc.com\/#organization"},"image":{"@id":"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/#primaryimage"},"thumbnailUrl":"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2024\/03\/news-nectin.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/","url":"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/","name":"Nectin Therapeutics has been honored with the esteemed European Innovation Council (EIC) Accelerator funding. - Peregrine","isPartOf":{"@id":"https:\/\/www.peregrinevc.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/#primaryimage"},"image":{"@id":"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/#primaryimage"},"thumbnailUrl":"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2024\/03\/news-nectin.jpg","datePublished":"2024-03-18T15:30:27+00:00","dateModified":"2024-03-19T10:44:03+00:00","breadcrumb":{"@id":"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/#primaryimage","url":"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2024\/03\/news-nectin.jpg","contentUrl":"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2024\/03\/news-nectin.jpg","width":800,"height":400,"caption":"Nectin Therapeutics has been honored with the esteemed European Innovation Council (EIC) Accelerator funding."},{"@type":"BreadcrumbList","@id":"https:\/\/www.peregrinevc.com\/news\/nectin-therapeutics-has-been-honored-with-the-esteemed-european-innovation-council-eic-accelerator-funding\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.peregrinevc.com\/"},{"@type":"ListItem","position":2,"name":"Nectin Therapeutics has been honored with the esteemed European Innovation Council (EIC) Accelerator funding."}]},{"@type":"WebSite","@id":"https:\/\/www.peregrinevc.com\/#website","url":"https:\/\/www.peregrinevc.com\/","name":"Peregrine","description":"Venture Capital Fund","publisher":{"@id":"https:\/\/www.peregrinevc.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.peregrinevc.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.peregrinevc.com\/#organization","name":"PEREGRINE VENTURES","url":"https:\/\/www.peregrinevc.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.peregrinevc.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/02\/logo.svg","contentUrl":"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/02\/logo.svg","width":1,"height":1,"caption":"PEREGRINE VENTURES"},"image":{"@id":"https:\/\/www.peregrinevc.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.peregrinevc.com\/#\/schema\/person\/7cf18986a83be1600a6ceecb2f6ed521","name":"Amit Alfasi","url":"https:\/\/www.peregrinevc.com\/author\/amit\/"}]}},"_links":{"self":[{"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/posts\/4682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/comments?post=4682"}],"version-history":[{"count":4,"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/posts\/4682\/revisions"}],"predecessor-version":[{"id":4691,"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/posts\/4682\/revisions\/4691"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/media\/4765"}],"wp:attachment":[{"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/media?parent=4682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/categories?post=4682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/tags?post=4682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}